<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01662193</url>
  </required_header>
  <id_info>
    <org_study_id>190136</org_study_id>
    <nct_id>NCT01662193</nct_id>
  </id_info>
  <brief_title>Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients</brief_title>
  <official_title>Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The epidemic of type 2 diabetes is an enormous public health problem in all parts of the
      world, with 366 million cases by 2030. Chronic inflammation has been postulated to play a
      role in the pathogenesis of type 2 diabetes. High levels of adiponectin and inflammatory
      biomarkers are known as a new risk factor for diabetes. There is accumulating evidence
      suggesting that altered vitamin D and calcium homeostasis affect the development of type 2
      diabetes, but it is still unclear whether that effects are through reducing the level of
      adipocytokines and inflammatory biomarkers or not. This study has been designed to evaluate
      the effects of vitamin D and calcium supplementations alone and in combination on
      inflammatory biomarkers and adypocytokines in type 2 diabetic patients.

      This study is a single masked, controlled randomized trial with period of 8 weeks. 120
      diabetic patients who met the inclusion criteria will enroll in this study. Subjects will
      randomly assign in to four groups. Randomization will be achieved by permuted blocks with
      stratification by age, sex, BMI, type of diabetes and dose of medication. Group1 will receive
      50000 IU of vitamin D3 per week plus calcium placebo, group2 will received 1000 mg of calcium
      carbonate per day plus vitamin D placebo, group 3 will receive 50000 IU of vitamin D3 plus
      100 of mg calcium carbonate per day and group four will receive calcium and vitamin D
      placebos. Total cholesterol, HDL, LDL, serum triglyceride, serum glucose, serum insulin,
      HbA1C, leptin, adiponectin and inflammatory biomarkers such as TNF-alpha, IL-6 and high
      sensitivity C reactive protein (hs-CRP) will be determine by taking blood samples at the
      baseline and at the end of intervention. Systolic and diastolic blood pressure and
      anthropometric measurements (height, weight, hip and waist circumferences) will be measured
      at the baseline and after 8 weeks of intervention. 3 dietary records and 3 physical activity
      records will be taken at 2,4 and 6 week of intervention to make sure that all subjects
      maintain their usual diet and physical activity during intervention.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in inflammatory biomarkers from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>including:IL-6, TNF-alpha, hs-CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in adipocytokines from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>including: adiponectin and leptin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in weight (Kg) from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in lipid profile from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>including: LDL, HDL, total cholesterol, TG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in serum Glucose from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in height (Cms) from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in hip circumference (Cms) from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in waist circumference (Cms) from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in serum Insulin from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in HbA1C from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood pressure from baseline at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Nutritional and Metabolic Disease</condition>
  <arm_group>
    <arm_group_label>vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vitamin D3 supplement 50000 IU vitamin D3 per week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>calcium supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>calcium supplement 1000 mg calcium carbonate daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin D and calcium supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vitamin D3 and calcium supplementation 50000 IU vitamin D3 per week and 1000 mg calcium carbonate daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3 supplement</intervention_name>
    <arm_group_label>vitamin D3</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>calcium supplement</intervention_name>
    <arm_group_label>calcium supplement</arm_group_label>
    <other_name>calcium carbonate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3 and calcium supplement</intervention_name>
    <arm_group_label>vitamin D and calcium supplement</arm_group_label>
    <other_name>cholecalciferol and calcium carbonate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more than 30 years old

          -  have no history of renal failure, cancer, liver diseases, thyroid diseases or any
             other inflammatory diseases

          -  have no allergy

          -  do not use any tobacco products

          -  not using corticosteroids

          -  not consuming any kinds of vitamin D or calcium supplement

          -  have not more than 4 kilograms weight change during last 3 months

        Exclusion Criteria:

          -  pregnancy

          -  insulin dependent diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>marjan tabesh, MS</last_name>
    <phone>00989131664159</phone>
    <email>tabesh@hlth.mui.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical School of Isfahan</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>esmaillzadeh, PhD</last_name>
      <email>esmaillzadeh@hlth.mui.ac.ir</email>
    </contact>
    <investigator>
      <last_name>marjan tabesh, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2012</study_first_submitted>
  <study_first_submitted_qc>August 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2012</study_first_posted>
  <last_update_submitted>August 10, 2012</last_update_submitted>
  <last_update_submitted_qc>August 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Marjan Tabesh</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Cholecalciferol</keyword>
  <keyword>Calciol</keyword>
  <keyword>vitamin D3</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Diabetes Mellitus Type 2</keyword>
  <keyword>glucose metabolism disorders</keyword>
  <keyword>ergocalciferol</keyword>
  <keyword>calcium</keyword>
  <keyword>adipicytokines</keyword>
  <keyword>inflammatory biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

